Pro Medicus (ASX:PME) said that its wholly-owned US unit, Visage Imaging, signed a multi-year research collaboration agreement with the University of California San Francisco as a framework for collaboration to facilitate the development and commercialization leveraging the Visage AI Accelerator platform, according to a Tuesday Australian bourse filing.
The agreement has the potential to develop artificial intelligence products to meet clinical goals and ultimately lead to better patient outcomes, Malte Westerhoff, Visage Imaging's global chief technology officer, said.
The research collaboration builds on the existing UCSF Visage 7 Viewer agreement.
Pro Medicus' shares fell past 1% in recent trading on Tuesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。